The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research.
Batten disease
Disease mechanism
Experimental therapy
Lysosomal storage disorder
Model organism
Neuronal ceroid lipofuscinosis
Pathology
Journal
Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
received:
26
06
2019
revised:
14
11
2019
accepted:
15
11
2019
pubmed:
30
11
2019
medline:
22
12
2020
entrez:
30
11
2019
Statut:
ppublish
Résumé
The NCLs (neuronal ceroid lipofuscinosis) are forms of neurodegenerative disease that affect people of all ages and ethnicities but are most prevalent in children. Commonly known as Batten disease, this debilitating neurological disorder is comprised of 13 different subtypes that are categorized based on the particular gene that is mutated (CLN1-8, CLN10-14). The pathological mechanisms underlying the NCLs are not well understood due to our poor understanding of the functions of NCL proteins. Only one specific treatment (enzyme replacement therapy) is approved, which is for the treating the brain in CLN2 disease. Hence there remains a desperate need for further research into disease-modifying treatments. In this review, we present and evaluate the genes, proteins and studies performed in the social amoeba, nematode, fruit fly, zebrafish, mouse and large animals pertinent to NCL. In particular, we highlight the use of multicellular model organisms to study NCL protein function, pathology and pathomechanisms. Their use in testing novel therapeutic approaches is also presented. With this information, we highlight how future research in these systems may be able to provide new insight into NCL protein functions in human cells and aid in the development of new therapies.
Identifiants
pubmed: 31783156
pii: S0925-4439(19)30340-0
doi: 10.1016/j.bbadis.2019.165614
pii:
doi:
Substances chimiques
Membrane Proteins
0
Tpp1 protein, mouse
0
Tripeptidyl-Peptidase 1
0
TPP1 protein, human
EC 3.4.14.9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
165614Subventions
Organisme : Medical Research Council
ID : MR/P012965/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/N008472/1
Pays : United Kingdom
Organisme : CIHR
ID : PJT165873
Pays : Canada
Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.